Haselmeier: White Papers

Injection pens for effective clinical trials
Thursday, May 03, 2018 Due to the high cost pressure in health services, it is necessary for a drug to be safe, effective and more economical than existing forms of therapy. Haselmeier’s injection pens...

New management organisation of the Haselmeier Group
Monday, November 10, 2014 The Haselmeier Group has restructured its management organisation, introducing a Group Executive Board tasked with coordination and decision-making for all Haselmeier locations. The...

Haselmeier announces the launch of INSUPen® EZ in India by Biocon
Tuesday, October 28, 2014 Haselmeier announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen® EZ is a second generation pen and follows on...

Haselmeier announces the market launch of JuniorSTAR by Sanofi
Friday, April 04, 2014 The new and reusable half-unit insulin pen JuniorSTAR® is now available in Germany.

Haselmeier announces the CE mark for JuniorSTAR half-unit insulin pen
Monday, February 10, 2014 Haselmeier has announced the CE mark of JuniorSTAR® by Sanofi.

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.